Literature DB >> 14569988

The subject advocate: protecting the interests of participants with fluctuating decisionmaking capacity.

Scott Stroup1, Paul Appelbaum.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2003        PMID： 14569988

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  11 in total

Review 1.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

2.  Financial capacity in persons with schizophrenia and serious mental illness: clinical and research ethics aspects.

Authors:  Daniel C Marson; Robert Savage; Jacqueline Phillips
Journal:  Schizophr Bull       Date:  2005-11-17       Impact factor: 9.306

3.  Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

Authors:  T Scott Stroup; Paul S Appelbaum; Hongbin Gu; Spencer Hays; Marvin S Swartz; Richard S E Keefe; Scott Y Kim; Theo C Manschreck; Roger A Boshes; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2011-05-10       Impact factor: 4.939

4.  Decisional capacity of patients with schizophrenia to consent to research: taking stock.

Authors:  Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

Review 5.  Consent in impaired populations.

Authors:  Paul S Appelbaum
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

6.  Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study.

Authors:  T Scott Stroup; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-11-10       Impact factor: 9.306

7.  Clinical and ethical aspects of financial capacity in dementia: a commentary.

Authors:  Daniel C Marson
Journal:  Am J Geriatr Psychiatry       Date:  2013-04       Impact factor: 4.105

8.  Research subject advocacy: program implementation and evaluation at clinical and translational science award centers.

Authors:  Rhonda G Kost; Carson Reider; Julie Stephens; Kathryn G Schuff
Journal:  Acad Med       Date:  2012-09       Impact factor: 6.893

9.  Neuroethics of Neuromodulation: An Update.

Authors:  Peter Zuk; Laura Torgerson; Demetrio Sierra-Mercado; Gabriel Lázaro-Muñoz
Journal:  Curr Opin Biomed Eng       Date:  2018-10-26

10.  Advocacy Recruiting for Huntington's Disease Clinical Trials.

Authors:  Lavonne Goodman; Cherrie Sia; Roger Carnes; Louise Vetter; Fred Taubman; Charles S Venuto; Andrew McGarry; Karl Kieburtz; Pinky Agarwal
Journal:  PLoS Curr       Date:  2011-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.